Table 3 Thrombocytopenia and its associated factors after HAART initiation in HIV positive patients attending Black Lion Specialized Hospital, Addis Ababa, Ethiopia, 2017
Variables | Thrombocytopenia | Adjusted OR(95%CI) | P value | |
|---|---|---|---|---|
Yes (%) | No (%) | |||
Age(in years) | ||||
20–29 | 2(7.1%) | 26 (92.6%) | 0.95(0.13–6.98) | |
30–39 | 1(1.7%) | 57(98.3%) | 0.18(0.02–1.94) | 0.53 |
40–49 | 4(6.6%) | 57(93.4%) | 0.66(0.13–3.41) | |
≥ 50 | 3(10.3%) | 26 (89.7%) | 1 | |
Sex | ||||
Male | 7(10.1%) | 62(89.8%) | 3.45(0.79–15.05) | 0.09 |
Female | 3(2.8%) | 104(97.2%) | 1 | |
Types of ART regimen | ||||
TDF based | 6(4.8%) | 119(95.2%) | 0.86(0.22–3.38) | 0.83 |
AZT based | 4(7.8%) | 47(92.2%) | 1 | |
CD4 count (cells/mm3) | ||||
< 200 | 5(12.2%) | 36(87.8%) | 3.39(0.74–15.63) | 0.19 |
200–349 | 2(3.8%) | 51(96.2%) | 0.96(0.15–6.29) | |
≥ 350 | 3(3.6%) | 79(96.3%) | 1 | |